Ii. Wistuba et al., Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer, CANCER RES, 59(8), 1999, pp. 1973-1979
Allelic Losses on the short arm of chromosome 8 (8p) have been reported as
frequent events in several cancers, including Lung. However, no comprehensi
ve mapping analysis of chromosome 8p in Lung cancer tumors has been perform
ed, and no data are available about the stage at which these abnormalities
occur during the multistage development of lung cancer. Using 26 microsatel
lite markers, we mapped the chromosome 8 regions frequently deleted in lung
cancer in 13 small cell carcinoma and 17 non-small cell lung carcinoma cel
l Lines and in 68 microdissected archival primary lung tumors (22 small cel
l lung carcinomas, 25 squamous cell carcinomas, and 21 adenocarcinomas), We
also studied the role of 8p deletions in lung cancer pathogenesis by exami
ning 95 microdissected normal epithelium and preneoplastic samples from 11
surgically resected squamous cell Lung carcinomas and from 58 bronchoscopy
biopsy samples obtained from 31 current and former smokers. High frequencie
s of deletions at 8p21-23 regions were detected in lung cancer cell lines a
nd in primary lung tumors. Deletions commenced early during the multistage
development of lung cancer at the hyperplasia/metaplasia stage in cancer pa
tients and in smokers without cancer. Allelic deletions persisted for up to
48 years after smoking cessation. There was a progressive increase of the
overall 8p21-23 loss of heterozygosity frequency and in the size of the del
eted region with increasing severity of histopathological preneoplastic cha
nges. In epithelial samples from resected squamous cell Lung carcinomas, we
compared the presence of loss of heterozygosity at 8p21-23 with deletions
at chromosomes 3p and 9p, Of interest, the pattern of deletions was not ran
dom, and 8p21-23 allelic Losses always followed 3p deletions and usually fo
llowed 9p deletions. We conclude that 8p21-23 deletions are frequent and ea
rly events in the pathogenesis of Lung carcinomas.